{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:30:31Z","timestamp":1786728631936,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p>Dry eye disease (DED) is a common multi-factorial disease that is characterized by tear film instability. Diquafosol tetrasodium (DQS), an ophthalmic solution, has been shown to be beneficial in the treatment of DED. The goal of this study was to provide an update on the safety and efficacy of topical 3% DQS in treating DED patients. A thorough search for all the published randomized controlled trials (RCTs) up to March 31, 2022 in CENTRAL, PubMed, Scopus, and Google Scholar databases was performed. Data were reported as standardized mean difference (SMD) with 95% confidence interval (CI). Modified Jadad scale was used for sensitivity analysis. Funnel plot and Egger\u2019s regression test assessed the publication bias. Fourteen RCTs evaluating the safety and efficacy of topical 3% DQS treatment in DED patients were included. Eight included RCTs reported data on the DED after cataract surgery. Overall findings suggest that 3% DQS treatment in DED patients was associated with significantly better improvement at 4 weeks in tear breakup time, Schirmer test, fluorescein staining scores, and Rose Bengal staining score as compared to patients treated with others eye drops including artificial tears or 01% sodium hyaluronate. However, no significant difference in ocular surface disease index was observed. Our findings suggest that 3% DQS treatment is safer and had a superior efficacy compared to artificial tears or sodium hyaluronate for treating DED in general and DED after cataract surgery.<\/jats:p>","DOI":"10.4103\/ijo.ijo_268_23","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T11:10:52Z","timestamp":1680952252000},"page":"1304-1315","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials"],"prefix":"10.4103","volume":"71","author":[{"given":"Shuang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Beijing Jishuitan Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Jishuitan Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingnan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Jishuitan Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohua","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beijing Jishuitan Hospital, Xicheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease:Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-1-4615-2417-5_41","article-title":"Structure and function of the tear film","volume":"350","author":"Dilly","year":"1994","journal-title":"Adv Exp Med Biol"},{"issue":"2 Suppl 1","key":"R3-20240828","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00003226-200203001-00005","article-title":"Significance of mucin on the ocular surface","volume":"21","author":"Watanabe","year":"2002","journal-title":"Cornea"},{"key":"R4-20240828","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on Clinical Trials in Dry Eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"R5-20240828","first-page":"2602","article-title":"Alteration of mucin in human conjunctival epithelia in dry eye","volume":"39","author":"Danjo","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2147\/OPTH.S95242","article-title":"Tear film osmolarity and dry eye disease:A review of the literature","volume":"9","author":"Potvin","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"Suppl 1","key":"R7-20240828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.icu.0000512373.81749.b7","article-title":"Dysfunctional tear syndrome:Dry eye disease and associated tear film disorders-new strategies for diagnosis and treatment","volume":"27","author":"Milner","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.oftal.2010.12.010","article-title":"[Study of tear function and the conjunctival surface in diabetic patients","volume":"86","author":"Figueroa-Ortiz","year":"2011","journal-title":"Arch Soc Esp Oftalmol"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"e8174","DOI":"10.1097\/MD.0000000000008174","article-title":"Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery:A meta-analysis of randomized controlled trials","volume":"96","author":"Zhao","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"e78657","DOI":"10.1371\/journal.pone.0078657","article-title":"Incidence and pattern of dry eye after cataract surgery","volume":"8","author":"Kasetsuwan","year":"2013","journal-title":"PLoS One"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtos.2018.11.003","article-title":"The impact of dry eye disease treatment on patient satisfaction and quality of life:A review","volume":"17","author":"Gomes","year":"2019","journal-title":"Ocul Surf"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jcrs.2014.11.034","article-title":"Comparison of treatment with preservative-free versus preserved sodium hyaluronate 0.1% and fluorometholone 0.1% eyedrops after cataract surgery in patients with preexisting dry-eye syndrome","volume":"41","author":"Jee","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/bjophthalmol-2011-301448","article-title":"A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients","volume":"96","author":"Takamura","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/eye.2012.166","article-title":"Clinical evaluation of the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye syndrome:A prospective, randomized, multicenter study","volume":"26","author":"Kamiya","year":"2012","journal-title":"Eye (Lond)"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/ICO.0000000000000213","article-title":"Additive effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops","volume":"33","author":"Hwang","year":"2014","journal-title":"Cornea"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ajo.2013.11.017","article-title":"Combination therapy with diquafosol tetrasodium and sodium hyaluronate in patients with dry eye after laser in situ keratomileusis","volume":"157","author":"Toda","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.jcrs.2014.12.056","article-title":"Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery","volume":"41","author":"Mencucci","year":"2015","journal-title":"J Cataract Refract Surg"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3341\/kjo.2013.27.3.167","article-title":"The effect of topical cyclosporine 0.05% on dry eye after cataract surgery","volume":"27","author":"Chung","year":"2013","journal-title":"Korean J Ophthalmol"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajo.2013.09.009","article-title":"Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes","volume":"157","author":"Yokoi","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000492896","article-title":"Efficacy and safety of topical 3% diquafosol ophthalmic solution for the treatment of multifactorial dry eye disease:Meta-analysis of randomized clinical trials","volume":"61","author":"Nam","year":"2019","journal-title":"Ophthalmic Res"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000051263","article-title":"Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials","volume":"12","author":"Oremus","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.ophtha.2012.04.010","article-title":"Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome:A Japanese phase 2 clinical trial","volume":"119","author":"Matsumoto","year":"2012","journal-title":"Ophthalmology"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/ICO.0b013e3182930b1d","article-title":"Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye","volume":"32","author":"Shimazaki-Den","year":"2013","journal-title":"Cornea"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2015.12.002","article-title":"Clinical effects and safety of 3% diquafosol ophthalmic solution for patients with dry eye after cataract surgery:A randomized controlled trial","volume":"163","author":"Park","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/bjophthalmol-2014-306084","article-title":"A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore","volume":"99","author":"Gong","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3109\/02713683.2015.1122813","article-title":"The effect of topical diquafosol tetrasodium 3% on dry eye after cataract surgery","volume":"41","author":"Baek","year":"2016","journal-title":"Curr Eye Res"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2147\/OPTH.S129178","article-title":"Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye:A multicenter prospective randomized study","volume":"11","author":"Miyake","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/OPTH.S122542","article-title":"Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery","volume":"11","author":"Inoue","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s10792-017-0693-1","article-title":"Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye","volume":"38","author":"Cui","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12325-018-0685-1","article-title":"Randomized controlled study to investigate the effect of topical diquafosol tetrasodium on corneal sensitivity in short tear break-up time dry eye","volume":"35","author":"Kaido","year":"2018","journal-title":"Adv Ther"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"12659","DOI":"10.1038\/s41598-019-49159-0","article-title":"Effects of preservative-free 3% diquafosol in patients with pre-existing dry eye disease after cataract surgery:A randomized clinical trial","volume":"9","author":"Jun","year":"2019","journal-title":"Sci Rep"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1038\/s41598-021-88589-7","article-title":"A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0161-6420(92)31947-5","article-title":"Comparison of fluorescein and rose bengal staining","volume":"99","author":"Feenstra","year":"1992","journal-title":"Ophthalmology"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/archopht.1992.01080190090035","article-title":"What is actually stained by rose bengal?","volume":"110","author":"Feenstra","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/bjo.79.11.1007","article-title":"Sodium hyaluronate eyedrops in the treatment of dry eyes","volume":"79","author":"Shimmura","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/jop.2012.0246","article-title":"Effects of diquafosol tetrasodium administration on visual function in short break-up time dry eye","volume":"29","author":"Kaido","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1111\/aos.12443","article-title":"Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye","volume":"92","author":"Koh","year":"2014","journal-title":"Acta Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_268_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:29:36Z","timestamp":1786724976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_268_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_268_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2023-01-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}